| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/06/2007 | CN1973881A Medicine for promoting blood circulation, dispersing blood clots, eliminating swelling and pain, and dispelling wind and wetness |
| 06/06/2007 | CN1973880A Externally applied medicine for treating gouty arthritis and its prepn |
| 06/06/2007 | CN1973870A Application of kidney reinforcing and rheumatism treating bolus in treating gout in chronic period |
| 06/06/2007 | CN1973868A Application of middle jiao strengthening and Qi replenishing Chinese medicine prepn in preventing and treating osteoporosis |
| 06/06/2007 | CN1320118C Human bone morphogenic protein-4 mature peptide colibacillus high expression vector and its preparing method |
| 06/06/2007 | CN1319957C Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 06/06/2007 | CN1319593C Oral enteric-coated microsphere of Thymosin and preparation thereof |
| 06/06/2007 | CN1319577C Medicine for treating cervical disease and its preparation |
| 06/06/2007 | CN1319571C Chinese patent medicine for enterogastric heat retention waist and knee aching pain and joint tingling and its preparation |
| 06/06/2007 | CN1319569C Chinese medicine preparation for treating osteoporosis and fracture and preparation process thereof |
| 06/06/2007 | CN1319567C Chinese medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny |
| 06/06/2007 | CN1319560C Chinese medicine compound rheumatism preparation for improving bioavailability and medicine effect and preparing method |
| 06/06/2007 | CN1319546C Delayed-releasing preparation for treating osteoporosis |
| 06/06/2007 | CN1319540C Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 06/05/2007 | US7227031 Aspirin-triggered lipoxins as modulators of diseases associated with polymorphoneutrophil inflammation; antiinflammatory agents |
| 06/05/2007 | US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 06/05/2007 | US7227020 protein kinase inhibitors; asthma, psoriasis, antiinflammatory agents; inflammatory bowel disorders |
| 06/05/2007 | US7226972 Cosmetics, drugs |
| 06/05/2007 | US7226945 Estrogen receptor-β ligands |
| 06/05/2007 | US7226940 Such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 06/05/2007 | US7226921 An enzyme inhibitor of cysteine proteases, a morpholine-4-carboxyamide 1,3,4-oxadiazole derivatives; for treating arthritis, muscular dystrophy, inflammation, tumor, glomerulonephritis, malaria, periodontal disease |
| 06/05/2007 | US7226902 Complex of a TGF-beta binding protein and a BMP antagonist where the TGF-beta binding protein comprises a sclerostin polypeptide capable of specifically binding a first TGF-beta superfamily member polypeptide from a BMP-5 polypeptide and a BMP-6 polypeptide |
| 06/05/2007 | US7226587 To promote osteogenesis and therefore uses include fracture healing and repair and acceleration of fracture healing |
| 06/05/2007 | CA2411671C Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/05/2007 | CA2356294C Pharmaceutical compositions for treating bone lesions in multiple myeloma |
| 05/31/2007 | WO2007061924A2 Methods of treating cartilage defects |
| 05/31/2007 | WO2007061861A2 High-potency sweetener composition for treatment and/or prevention of osteoporosis and compositions sweetened therewith |
| 05/31/2007 | WO2007061783A1 Treatment and prevention of bone loss using resolvins |
| 05/31/2007 | WO2007060132A1 N-hydroxyamide derivatives and use thereof |
| 05/31/2007 | WO2007060028A1 Napthyridine compounds as rock inhibitors |
| 05/31/2007 | WO2007040438A3 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 05/31/2007 | WO2007037554A9 Adsorbent for advanced glycation endproducts |
| 05/31/2007 | WO2007034477A3 Modulation of osteoclast differentiation |
| 05/31/2007 | WO2007031785A3 Bisphosphonate formulation |
| 05/31/2007 | WO2007003957A3 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 05/31/2007 | WO2006074370A3 Agonists and antagonists of tnfrii/cd120b for treatment of immune-related diseases |
| 05/31/2007 | WO2006031353A3 Vascular endothelial growth factor fusion constructs and uses thereof |
| 05/31/2007 | US20070124837 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/31/2007 | US20070123549 platelet activating factor aceylhydrolase inhibitors such as 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5-ethylpyrimidin-4-one; for treatment of atherosclerosis |
| 05/31/2007 | US20070123543 Novel compounds |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | US20070123530 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 05/31/2007 | US20070123479 single chain antibody construct comprising binding domains specific for human CD3 and human CD19; anticarcinogenic biodrug for treating non-Hodgkin lymphoma |
| 05/31/2007 | DE102005057225A1 New 8-beta-substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders |
| 05/31/2007 | DE102005057224A1 New 9-alpha substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders |
| 05/31/2007 | CA2630551A1 N-hydroxyamide derivatives and use thereof |
| 05/31/2007 | CA2629569A1 Methods of treating cartilage defects |
| 05/31/2007 | CA2593718A1 Napthyridine compounds as rock inhibitors |
| 05/30/2007 | EP1790726A2 Modified and stabilized GDF propeptides and uses thereof |
| 05/30/2007 | EP1790725A2 Proteins named after FCTRX and nucleic acids encoding same |
| 05/30/2007 | EP1790651A1 A1 adenosine receptor antagonists |
| 05/30/2007 | EP1790644A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/30/2007 | EP1790642A1 Biologically active methylene blue derivatives |
| 05/30/2007 | EP1790641A1 Triazole derivative or salt thereof |
| 05/30/2007 | EP1790639A1 Compound containing basic group and use thereof |
| 05/30/2007 | EP1790352A1 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
| 05/30/2007 | EP1789421A1 Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 05/30/2007 | EP1789417A1 AMIDE DERIVATIVES OF 7-AMINO-3-PHENYL-DIHYDROPYRIMIDO [4,5-d]PYRIMIDINONES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS |
| 05/30/2007 | EP1789033A2 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 05/30/2007 | EP1427706B1 Substituted pyrazolo compounds for the treatment of inflammation |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 05/30/2007 | EP1248615B1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/30/2007 | EP1221973B1 CD40 antagonist for treating psoriasis |
| 05/30/2007 | EP0975754B1 Osteoprotegerin binding proteins and receptors |
| 05/30/2007 | EP0811383B1 Remedies for arthrosis deformans and inflammatory joint diseases |
| 05/30/2007 | EP0726954B2 Cytokine antagonists |
| 05/30/2007 | CN1972931A Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia |
| 05/30/2007 | CN1972680A Method for treatment or prevention of osteoporosis in individuals with high bone turnover |
| 05/30/2007 | CN1972665A Injectable depot compositions and uses thereof |
| 05/30/2007 | CN1972662A Personal care compositions with improved hyposensitivity |
| 05/30/2007 | CN1970547A Novel febuxostat crystal form and its preparation method |
| 05/30/2007 | CN1970067A Chinese medicinal formulation for treating vertebrae hyperosteogeny, protrusion of intervertebral disc and spinal stenosis |
| 05/30/2007 | CN1970057A Medicament for treating rheumatism |
| 05/30/2007 | CN1970047A Chinese medicine for treating bone disease and preparation process thereof |
| 05/30/2007 | CN1970046A Pills and capsules for repositioning protruded lumbar intervertebral discs and preparation process thereof |
| 05/30/2007 | CN1970045A Externally applied Chinese medicine for treating cervical and lumbar spondylosis |
| 05/30/2007 | CN1970044A Medicinal composition for treating rheumatoid arthritis and method for preparing same |
| 05/30/2007 | CN1970037A Medicated wine for treating cervical spondylopathy |
| 05/30/2007 | CN1970030A Chinese medicine for treating rheumatoid arthritis, preparation method and application thereof |
| 05/30/2007 | CN1970021A Chinese medicine for treating gout and preparation method thereof |
| 05/30/2007 | CN1969993A Externally applied medicament for dispelling wind, scattering cold, unblocking collaterals and stopping pain and preparation process thereof |
| 05/30/2007 | CN1969989A Capsule for unblocking collaterals to treat arthritis |
| 05/30/2007 | CN1969988A Chinese medicinal formulation for treating prostate disease, preparation process and quality control method thereof |
| 05/30/2007 | CN1969974A Medicated wine for treating traumatic injury |
| 05/30/2007 | CN1969972A Chinese medicinal powder for treating rheumatic disease |
| 05/30/2007 | CN1969971A Transdermal absorption formulation of total alkaloid of common monkshood root and preparation process thereof |
| 05/30/2007 | CN1969965A Ointment for treating bone injuries |
| 05/30/2007 | CN1969959A Externally applied medicament for treating bone fracture |
| 05/30/2007 | CN1969929A Dry coating sustained-release tablet for treating arthritis and preparation process thereof |
| 05/30/2007 | CN1969928A Enteric coated/sustained release formulation of triperygium wilfordii and preparation process thereof |
| 05/30/2007 | CN1969925A Tablet for promoting blood circulation to resolve blood stasis |
| 05/30/2007 | CN1969921A Application of 'Bi Tong Ning' as medicament for treating acute onset of gout |
| 05/30/2007 | CN1969909A Pharmaceutical composition for treating traumatic injury |
| 05/30/2007 | CN1969841A Herbal extract for treating rheumatoid arthritis |
| 05/30/2007 | CN1969812A Fruit pulp for bathing and bathing method thereof |
| 05/30/2007 | CN1969805A Complete natural skin-tendering and wrinkle-removing cosmetic |
| 05/30/2007 | CN1969804A Skin care mask |
| 05/30/2007 | CN1318413C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |